Disease progression in patients with mild-to-moderate Alzheimer's disease treated with galantamine: Results of a two-year open-label studyMaren Gaudig,Ute Richarz,Klaus Rettig,Miriam Djelani,Barbara SchaubleAlzheimers & Dementia(2012)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要